Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CorVelCRVL +1.44%77 EBITDA Margin % is 19.30% as of Mar. 2026, which is 28% above its 10-year median of 15.11. GuruFocus rates CRVL with a GF Score™ of 77/100 and a GF Value™ of $102.51 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 370 Insurance companies, CorVel ranks better than 60% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. CorVel's EBITDA for the
three
months ended in Mar. 2026 was $48.0 Mil. CorVel's Revenue for the
three
months ended in Mar. 2026 was $248.5 Mil. Therefore, CorVel's EBITDA margin for the quarter that ended in Mar. 2026 was 19.30%.
CorVel (NAS:CRVL) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
CorVel EBITDA Margin % Related Terms
CorVel EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for CorVel's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Insurance Brokers subindustry, CorVel's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CorVel EBITDA Margin % vs Insurance Industry
For the Insurance industry and Financial Services sector, CorVel's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where CorVel's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CorVel (CRVL) has a EBITDA Margin % of 19.30% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CorVel and its competitors. This is 28% above median its historical median of 15.11. Over the past decade, CorVel's EBITDA Margin % has ranged from 12.48 to 18.25. According to the industry distribution chart, CorVel ranks #148 out of 370 companies in the Insurance industry, placing it in the top 40%.
Is CorVel's EBITDA Margin % too high?
CorVel's current EBITDA Margin % of 19.30% is 28% above median its 10-year median of 15.11. Over the past 10 years, this metric has ranged from a low of 12.48 to a high of 18.25. The Insurance industry median EBITDA Margin % is 14.77. CorVel's value of 19.30% is 30.7% above this industry median. Based on the distribution chart, CorVel ranks #148 out of 370 companies in the Insurance industry, which is above the industry midpoint. Overall, CorVel has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CorVel's EBITDA Margin % compare to ARX and BWIN?
According to the Insurance industry distribution chart, CorVel ranks #148 out of 370 companies for EBITDA Margin %. This puts CorVel in the upper half of its industry. The industry median EBITDA Margin % is 14.77. CorVel's value of 19.30% is 30.7% above this benchmark. Historically, CorVel's own EBITDA Margin % has ranged from 12.48 to 18.25 over the past decade. While the company's 10-year median is 15.11 vs. the industry median of 14.77, CorVel has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Insurance company?
The median EBITDA Margin % among Insurance companies is 14.77, based on 370 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CorVel's current EBITDA Margin % of 19.30% is 30.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CorVel and its competitors. For the Insurance industry, the median EBITDA Margin % is 14.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CorVel's current EBITDA Margin % is 19.30%, which is 28% above median its own 10-year median of 15.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CorVel stock overvalued right now?
Based on GuruFocus' analysis, CorVel (CRVL) is currently considered Significantly Undervalued. The stock's GF Value™ is $102.51, compared to a current price of $59.92 — trading 41.5% below its estimated fair value. The current EBITDA Margin % is 19.30%, which is 28% above median its 10-year median of 15.11 and 30.7% above the Insurance industry median of 14.77. CorVel's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CorVel (CRVL), the current EBITDA Margin % is 19.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CorVel (CRVL) Overvalued in 2026?
Based on GuruFocus' analysis, CorVel stock appears to be undervalued.
The current stock price of $59.92 is trading 41.5% below its estimated GF Value™ of $102.51.
GuruFocus considers CorVel to be Significantly Undervalued.
Key valuation signals for CRVL:
EBITDA Margin %: 19.30% (28% above median its 10-year median of 15.11)
GF Value™: $102.51 vs. price of $59.92 (41.5% below fair value)
Industry Position: 30.7% above the Insurance median (#148 of 370)
No single metric tells the full story. See the CRVL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
77GF Score
Get the complete analysis for CRVL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CRVL has been successfully added to your 
